Dr. Reddy's Laboratories
143 hedge funds and large institutions have $856M invested in Dr. Reddy's Laboratories in 2019 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 20 closing their positions.
53% more call options, than puts
Call options by funds: $817K | Put options by funds: $534K
46% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 39
11% more capital invested
Capital invested by funds: $770M → $856M (+$86.2M)
2.18% more ownership
Funds ownership: 61.52% → 63.69% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less funds holding
Funds holding: 146 → 143 (-3)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.8M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$12.1M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$6.59M |
| 4 |
Goldman Sachs
New York
|
+$4.93M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$4.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CLC
Charles-Lim Capital
Central,
Hong Kong
|
-$11M |
| 2 |
BlackRock
New York
|
-$7.28M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$4.31M |
| 4 |
Man Group
London,
United Kingdom
|
-$3.62M |
| 5 |
SGA
Sector Gamma AS
Oslo,
Norway
|
-$3.16M |
RDY Hedge Fund Activity: Q1 2019 in Review
143 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2019, worth a combined $856M — up 11% from $770M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of RDY and 18 opened new positions — a net loss of 2 holders — while 39 trimmed existing stakes and 57 added.
The largest buyer was Wellington Management Group, adding an estimated $13.8M. The largest seller was Charles-Lim Capital, cutting an estimated $11M.
- 143 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2019, down from 146 in Q4 2018.
- Funds reported $856M of Dr. Reddy's Laboratories stock for Q1 2019, up 11% quarter-over-quarter.
- 18 funds opened new Dr. Reddy's Laboratories positions in Q1 2019 and 20 closed out, a net change of -2 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2019 was Wellington Management Group, an estimated $13.8M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2019 was Charles-Lim Capital, an estimated $11M sold.
Based on aggregated 13F filings for Q1 2019.